笛卡兒治療公司

簡介

本頁面提供了有關 Timothy A Springer 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Timothy A Springer已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:RNAC / Cartesian Therapeutics, Inc. Director, 10% Owner 8,646,285
Director, 10% Owner 1,503,358
US:MORF / Morphic Holding, Inc. Director, 10% Owner 0
US:SRRK / Scholar Rock Holding Corporation 10% Owner 2,376,567
如何解讀這些圖表

以下圖表顯示了在Timothy A Springer進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

RNAC / Cartesian Therapeutics, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 RNAC / Cartesian Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2025-04-11 RNAC SPRINGER TIMOTHY A 6,412 10.7726 6,412 10.7726 69,074 89 13.7700 19,220 27.83
2025-04-11 RNAC SPRINGER TIMOTHY A 36,338 10.7726 36,338 10.7726 391,455
2025-04-10 RNAC SPRINGER TIMOTHY A 7,966 10.4345 7,966 10.4345 83,121
2025-04-10 RNAC SPRINGER TIMOTHY A 609 10.9231 609 10.9231 6,652
2025-04-10 RNAC SPRINGER TIMOTHY A 45,144 10.4345 45,144 10.4345 471,055
2025-04-10 RNAC SPRINGER TIMOTHY A 3,451 10.9231 3,451 10.9231 37,696
2025-04-09 RNAC SPRINGER TIMOTHY A 7,342 9.4264 7,342 9.4264 69,209
2025-04-09 RNAC SPRINGER TIMOTHY A 31 9.9509 31 9.9509 308
2025-04-09 RNAC SPRINGER TIMOTHY A 41,604 9.4264 41,604 9.4264 392,176
2025-04-09 RNAC SPRINGER TIMOTHY A 178 9.9509 178 9.9509 1,771
2025-03-20 RNAC SPRINGER TIMOTHY A 54,889 15.5877 54,889 15.5877 855,593
2025-03-19 RNAC SPRINGER TIMOTHY A 20,234 14.9729 20,234 14.9729 302,962
2025-03-18 RNAC SPRINGER TIMOTHY A 14,740 14.4233 14,740 14.4233 212,599
2025-01-14 RNAC SPRINGER TIMOTHY A 4,022 18.0000 4,022 18.0000 72,396
2025-01-13 RNAC SPRINGER TIMOTHY A 7,962 16.8576 7,962 16.8576 134,220
2025-01-13 RNAC SPRINGER TIMOTHY A 8,983 17.7822 8,983 17.7822 159,738
2024-12-23 RNAC SPRINGER TIMOTHY A 5,181 18.9996 5,181 18.9996 98,437
2024-12-20 RNAC SPRINGER TIMOTHY A 21,800 18.9435 21,800 18.9435 412,968
2024-12-19 RNAC SPRINGER TIMOTHY A 11,303 17.3858 11,303 17.3858 196,512
2024-12-19 RNAC SPRINGER TIMOTHY A 10,529 18.3496 10,529 18.3496 193,203
2024-12-19 RNAC SPRINGER TIMOTHY A 3,376 18.9280 3,376 18.9280 63,901
2024-11-18 RNAC SPRINGER TIMOTHY A 38,114 17.9579 38,114 17.9579 684,447
2024-11-18 RNAC SPRINGER TIMOTHY A 20,181 18.4201 20,181 18.4201 371,736
2024-11-15 RNAC SPRINGER TIMOTHY A 277,246 17.0938 277,246 17.0938 4,739,188
2024-11-14 RNAC SPRINGER TIMOTHY A 74,157 16.1916 74,157 16.1916 1,200,720
2024-11-14 RNAC SPRINGER TIMOTHY A 22,242 16.9695 22,242 16.9695 377,436
2024-10-04 RNAC SPRINGER TIMOTHY A 9,892 21.3501 9,892 21.3501 211,195
2024-10-04 RNAC SPRINGER TIMOTHY A 48,880 22.3542 48,880 22.3542 1,092,673
2024-10-04 RNAC SPRINGER TIMOTHY A 16,650 23.5659 16,650 23.5659 392,372
2024-10-04 RNAC SPRINGER TIMOTHY A 4,879 23.9330 4,879 23.9330 116,769
2024-10-03 RNAC SPRINGER TIMOTHY A 29,847 18.2456 29,847 18.2456 544,576
2024-10-03 RNAC SPRINGER TIMOTHY A 10,249 19.0125 10,249 19.0125 194,859
2024-10-03 RNAC SPRINGER TIMOTHY A 50,489 20.1802 50,489 20.1802 1,018,878
2024-10-03 RNAC SPRINGER TIMOTHY A 21,278 21.1749 21,278 21.1749 450,560
2024-10-03 RNAC SPRINGER TIMOTHY A 8,043 21.8625 8,043 21.8625 175,840
2024-10-02 RNAC SPRINGER TIMOTHY A 5,514 17.3779 5,514 17.3779 95,822
2024-08-12 RNAC SPRINGER TIMOTHY A 8,016 12.7205 8,016 12.7205 101,968
2024-03-18 RNAC SPRINGER TIMOTHY A 19,044 0.5985 635 17.9550 11,398
2024-03-18 RNAC SPRINGER TIMOTHY A 800 0.6100 27 18.3000 488
2024-03-15 RNAC SPRINGER TIMOTHY A 537,500 0.5852 17,917 17.5560 314,545
2024-03-15 RNAC SPRINGER TIMOTHY A 1,200 0.5600 40 16.8000 672
2024-03-14 RNAC SPRINGER TIMOTHY A 648,372 0.5424 21,612 16.2720 351,677
2024-03-14 RNAC SPRINGER TIMOTHY A 2,000 0.5305 67 15.9150 1,061
2024-03-13 RNAC SPRINGER TIMOTHY A 3,200 0.5837 107 17.5110 1,868
2024-03-12 RNAC SPRINGER TIMOTHY A 1,200 0.6122 40 18.3660 735
2024-03-11 RNAC SPRINGER TIMOTHY A 1,200 0.6541 40 19.6230 785
2024-03-08 RNAC SPRINGER TIMOTHY A 4,800 0.6639 160 19.9170 3,187
2024-02-07 RNAC SPRINGER TIMOTHY A 2,400 0.6563 80 19.6890 1,575
2024-02-06 RNAC SPRINGER TIMOTHY A 800 0.6500 27 19.5000 520
2024-01-17 RNAC SPRINGER TIMOTHY A 800 0.6900 27 20.7000 552
2022-04-11 SELB SPRINGER TIMOTHY A 6,681,600 6,681,600
2021-12-15 SELB SPRINGER TIMOTHY A 211,190 2.9883 211,190 2.9883 631,099
2021-12-13 SELB SPRINGER TIMOTHY A 14,592 2.9805 14,592 2.9805 43,491
2021-12-10 SELB SPRINGER TIMOTHY A 58,681 2.9897 58,681 2.9897 175,439
2021-12-09 SELB SPRINGER TIMOTHY A 3,748,000 3.0600 3,748,000 3.0600 11,468,880
2021-05-26 SELB SPRINGER TIMOTHY A 926,170 4.0011 926,170 4.0011 3,705,699
2021-05-25 SELB SPRINGER TIMOTHY A 383,830 3.5487 383,830 3.5487 1,362,098
2021-05-24 SELB SPRINGER TIMOTHY A 590,000 3.3764 590,000 3.3764 1,992,076
2021-05-21 SELB SPRINGER TIMOTHY A 2,773,479 3.1900 2,773,479 3.1900 8,847,398
2020-10-23 SELB SPRINGER TIMOTHY A 994,488 2.7147 994,488 2.7147 2,699,737
2020-10-22 SELB SPRINGER TIMOTHY A 1,770,204 2.6306 1,770,204 2.6306 4,656,699
2020-10-21 SELB SPRINGER TIMOTHY A 880,000 2.4994 880,000 2.4994 2,199,472
2020-10-20 SELB SPRINGER TIMOTHY A 910,000 2.2123 910,000 2.2123 2,013,193
2020-10-19 SELB SPRINGER TIMOTHY A 759,500 2.3634 759,500 2.3634 1,795,002
2020-10-16 SELB SPRINGER TIMOTHY A 218,196 2.4200 218,196 2.4200 528,034
2020-10-09 SELB SPRINGER TIMOTHY A 276,703 1.9966 276,703 1.9966 552,465
2020-10-08 SELB SPRINGER TIMOTHY A 530,441 1.8868 530,441 1.8868 1,000,836
2020-10-07 SELB SPRINGER TIMOTHY A 654,953 1.6468 654,953 1.6468 1,078,577
2020-10-06 SELB SPRINGER TIMOTHY A 2,000,000 1.6829 2,000,000 1.6829 3,365,800
2019-08-14 SELB SPRINGER TIMOTHY A 10,000 1.7415 10,000 1.7415 17,415
2019-01-25 SELB SPRINGER TIMOTHY A 4,000,000 1.5000 4,000,000 1.5000 6,000,000
2019-01-25 SELB SPRINGER TIMOTHY A 66,666 1.5000 66,666 1.5000 99,999
2017-11-14 SELB SPRINGER TIMOTHY A 57,598 9.2728 57,598 9.2728 534,095
2017-11-10 SELB SPRINGER TIMOTHY A 21,586 9.0425 21,586 9.0425 195,191
2017-11-10 SELB SPRINGER TIMOTHY A 4,752 9.0290 4,752 9.0290 42,906
2017-11-10 SELB SPRINGER TIMOTHY A 4,752 9.0290 4,752 9.0290 42,906
2017-11-09 SELB SPRINGER TIMOTHY A 21,100 9.3314 21,100 9.3314 196,893
2017-11-09 SELB SPRINGER TIMOTHY A 900 9.7407 900 9.7407 8,767
2017-11-09 SELB SPRINGER TIMOTHY A 4,900 9.3271 4,900 9.3271 45,703
2017-11-09 SELB SPRINGER TIMOTHY A 100 9.7800 100 9.7800 978
2017-06-27 SELB SPRINGER TIMOTHY A 338,791 17.7100 338,791 17.7100 5,999,989
2017-06-01 SELB SPRINGER TIMOTHY A 518 13.7500 518 13.7500 7,122
2017-05-18 SELB SPRINGER TIMOTHY A 4,860 14.0000 4,860 14.0000 68,040
2017-05-17 SELB SPRINGER TIMOTHY A 11,244 14.0060 11,244 14.0060 157,483
2016-06-27 SELB TAS Partners, LLC 710,000 14.0000 710,000 14.0000 9,940,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

RNAC / Cartesian Therapeutics, Inc. Insider Trades
RNAC / Cartesian Therapeutics, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 RNAC / Cartesian Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

RNAC / Cartesian Therapeutics, Inc. Insider Trades
SRRK / Scholar Rock Holding Corporation內部人士買入 - 短期收益分析

在這一部分，我們分析了在 RNAC / Cartesian Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2018-05-29 SRRK SPRINGER TIMOTHY A 71,428 14.0000 71,428 14.0000 999,992 197 28.77 1,054,992 105.50

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SRRK / Scholar Rock Holding Corporation Insider Trades
SRRK / Scholar Rock Holding Corporation內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 RNAC / Cartesian Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SRRK / Scholar Rock Holding Corporation Insider Trades
歷史內部人交易

該表格顯示了由 Timothy A Springer 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2026-01-06 2026-01-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		A - Award 2,600 8,646,285 0.03
2025-04-11 2025-04-11 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 36,338 656,513 5.86 10.77 391,455 7,072,352
2025-04-11 2025-04-11 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 6,412 8,643,685 0.07 10.77 69,074 93,114,961
2025-04-11 2025-04-10 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 3,451 620,175 0.56 10.92 37,696 6,774,234
2025-04-11 2025-04-10 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 45,144 616,724 7.90 10.43 471,055 6,435,207
2025-04-11 2025-04-10 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 609 8,637,273 0.01 10.92 6,652 94,345,797
2025-04-11 2025-04-10 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 7,966 8,636,664 0.09 10.43 83,121 90,119,271
2025-04-11 2025-04-09 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 178 571,580 0.03 9.95 1,771 5,687,735
2025-04-11 2025-04-09 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 41,604 571,402 7.85 9.43 392,176 5,386,264
2025-04-11 2025-04-09 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 31 8,628,698 0.00 9.95 308 85,863,311
2025-04-11 2025-04-09 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 7,342 8,628,667 0.09 9.43 69,209 81,337,267
2025-04-11 2025-04-11 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 53,706 1,503,358 3.70 16.31 875,945 24,519,769
2025-04-11 2025-04-11 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 9,478 4,334,846 0.22 16.31 154,586 70,701,338
2025-04-11 2025-04-10 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 45,858 1,449,652 3.27 16.73 767,204 24,252,678
2025-04-11 2025-04-10 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 8,092 4,325,368 0.19 16.73 135,379 72,363,407
2025-04-11 2025-04-09 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 4,856 1,403,794 0.35 15.23 73,957 21,379,783
2025-04-11 2025-04-09 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 16,215 1,398,938 1.17 14.62 237,063 20,452,474
2025-04-11 2025-04-09 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 857 4,317,276 0.02 15.23 13,052 65,752,113
2025-04-11 2025-04-09 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 2,861 4,316,419 0.07 14.62 41,828 63,106,046
2025-04-09 2025-04-07 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 412,500 1,382,723 42.52 17.10 7,053,750 23,644,563
2025-04-09 2025-04-07 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 87,500 4,313,558 2.07 17.10 1,496,250 73,761,842
2025-03-20 2025-03-20 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 54,889 8,621,325 0.64 15.59 855,593 134,386,628
2025-03-20 2025-03-19 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 20,234 8,566,436 0.24 14.97 302,962 128,264,390
2025-03-20 2025-03-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 14,740 8,546,202 0.17 14.42 212,599 123,264,435
2025-02-07 2025-02-05 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 660,000 970,223 212.75 50.00 33,000,000 48,511,150
2025-02-07 2025-02-05 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 129,294 4,226,058 3.16 54.14 6,999,977 228,798,780
2025-01-15 2025-01-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 4,022 8,531,462 0.05 18.00 72,396 153,566,316
2025-01-15 2025-01-13 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 8,983 8,527,440 0.11 17.78 159,738 151,636,644
2025-01-15 2025-01-13 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 7,962 8,518,457 0.09 16.86 134,220 143,600,741
2025-01-06 2025-01-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		A - Award 2,600 8,510,495 0.03
2024-12-23 2024-12-23 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 5,181 8,507,895 0.06 19.00 98,437 161,646,602
2024-12-23 2024-12-20 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 21,800 8,502,714 0.26 18.94 412,968 161,071,163
2024-12-23 2024-12-19 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 3,376 8,480,914 0.04 18.93 63,901 160,526,740
2024-12-23 2024-12-19 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 10,529 8,477,538 0.12 18.35 193,203 155,559,431
2024-12-23 2024-12-19 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 11,303 8,467,009 0.13 17.39 196,512 147,205,725
2024-11-18 2024-11-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 20,181 8,455,706 0.24 18.42 371,736 155,754,950
2024-11-18 2024-11-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 38,114 8,435,525 0.45 17.96 684,447 151,484,314
2024-11-18 2024-11-15 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 277,246 8,397,411 3.41 17.09 4,739,188 143,543,664
2024-11-18 2024-11-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 22,242 8,120,165 0.27 16.97 377,436 137,795,140
2024-11-18 2024-11-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 74,157 8,097,923 0.92 16.19 1,200,720 131,118,330
2024-10-24 2024-10-22 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 300,000 4,096,764 7.90 33.59 10,077,000 137,610,303
2024-10-04 2024-10-04 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 4,879 8,023,766 0.06 23.93 116,769 192,032,792
2024-10-04 2024-10-04 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 16,650 8,018,887 0.21 23.57 392,372 188,972,289
2024-10-04 2024-10-04 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 48,880 8,002,237 0.61 22.35 1,092,673 178,883,606
2024-10-04 2024-10-04 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 9,892 7,953,357 0.12 21.35 211,195 169,804,967
2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 8,043 7,943,465 0.10 21.86 175,840 173,664,004
2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 21,278 7,935,422 0.27 21.17 450,560 168,031,767
2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 50,489 7,914,144 0.64 20.18 1,018,878 159,709,009
2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 10,249 7,863,655 0.13 19.01 194,859 149,507,741
2024-10-04 2024-10-03 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 29,847 7,853,406 0.38 18.25 544,576 143,290,105
2024-10-04 2024-10-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		J - Other 317,879 330,695 2,480.33
2024-10-04 2024-10-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		J - Other -2,119,193 529,798 -80.00
2024-10-04 2024-10-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 5,514 7,823,559 0.07 17.38 95,822 135,957,026
2024-10-04 2024-10-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		J - Other 1,801,314 7,818,045 29.94
2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		M - Exercise 1,307 12,816 11.36
2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock 		M - Exercise -1,307 0 -100.00
2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		M - Exercise 721,361 2,648,991 37.42
2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock 		M - Exercise -721,361 0 -100.00
2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		M - Exercise 1,636,832 6,016,731 37.37
2024-09-27 2024-09-25 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock 		M - Exercise -1,636,832 0 -100.00
2024-09-26 2024-09-26 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 2,400 3,796,764 0.06 30.87 74,088 117,206,105
2024-09-26 2024-09-26 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 4,070 3,794,364 0.11 30.10 122,507 114,210,356
2024-09-26 2024-09-26 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 18,999 3,790,294 0.50 29.13 553,441 110,411,264
2024-09-26 2024-09-26 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		P - Purchase 24,531 3,771,295 0.65 28.16 690,793 106,199,667
2024-09-26 2024-09-24 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		J - Other 186,134 186,134
2024-09-26 2024-09-24 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		J - Other 1,054,759 3,746,764 39.18
2024-09-26 2024-09-24 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		J - Other -1,240,893 310,223 -80.00
2024-08-20 2024-08-16 4 MORF Morphic Holding, Inc.
Common Stock 		U - Other -42,873 0 -100.00
2024-08-20 2024-08-16 4 MORF Morphic Holding, Inc.
Common Stock 		U - Other -2,768,893 0 -100.00
2024-08-20 2024-08-16 4 MORF Morphic Holding, Inc.
Common Stock 		U - Other -4,608,052 0 -100.00
2024-08-14 2024-08-12 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 8,016 11,509 229.49 12.72 101,968 146,400
2024-07-05 2024-07-02 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock 		A - Award 1,307 1,307 20.00 26,140 26,140
2024-07-05 2024-07-02 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock 		A - Award 721,361 721,361 20.00 14,427,220 14,427,220
2024-07-05 2024-07-02 4 RNAC Cartesian Therapeutics, Inc.
Series B Non-Voting Convertible Preferred Stock 		A - Award 1,636,832 1,636,832 20.00 32,736,640 32,736,640
2024-06-24 2024-06-20 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		A - Award 1,551,116 1,551,116
2024-06-24 2024-06-20 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		A - Award 2,692,005 2,692,005
2024-04-10 2024-04-08 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		M - Exercise 826,169 1,927,630 75.01
2024-04-10 2024-04-08 4 RNAC Cartesian Therapeutics, Inc.
Series A Non-Voting Convertible Preferred Stock 		M - Exercise -24,785 0 -100.00
2024-04-10 2024-04-08 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		M - Exercise 4,130,846 4,379,899 1,658.62
2024-04-10 2024-04-08 4 RNAC Cartesian Therapeutics, Inc.
Series A Non-Voting Convertible Preferred Stock 		M - Exercise -123,925 0 -100.00
2024-03-28 2024-03-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 800 104,818 0.77 0.61 488 63,939
2024-03-28 2024-03-15 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 1,200 104,018 1.17 0.56 672 58,250
2024-03-28 2024-03-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 2,000 102,818 1.98 0.53 1,061 54,545
2024-03-28 2024-03-13 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 3,200 100,818 3.28 0.58 1,868 58,847
2024-03-28 2024-03-12 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 1,200 97,618 1.24 0.61 735 59,762
2024-03-28 2024-03-11 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 1,200 96,418 1.26 0.65 785 63,067
2024-03-28 2024-03-08 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 4,800 95,218 5.31 0.66 3,187 63,215
2024-03-28 2024-02-07 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 2,400 90,418 2.73 0.66 1,575 59,341
2024-03-28 2024-02-06 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 800 88,018 0.92 0.65 520 57,212
2024-03-28 2024-01-17 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 800 87,218 0.93 0.69 552 60,180
2024-03-26 2024-03-26 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		M - Exercise 1,970,443 33,043,849 6.34 1.46 2,876,847 48,244,020
2024-03-20 2024-03-18 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 19,044 31,073,406 0.06 0.60 11,398 18,597,433
2024-03-18 2024-03-15 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 537,500 31,054,362 1.76 0.59 314,545 18,173,013
2024-03-18 2024-03-14 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		P - Purchase 648,372 30,516,862 2.17 0.54 351,677 16,552,346
2024-01-04 2024-01-02 4 RNAC Cartesian Therapeutics, Inc.
Common Stock 		A - Award 178,000 7,471,625 2.44
2023-11-15 2023-11-15 4 RNAC Cartesian Therapeutics, Inc.
Series A Convertible Preferred Stock 		A - Award 123,925 123,925 403.47 49,999,998 49,999,998
2023-11-15 2023-11-15 4 RNAC Cartesian Therapeutics, Inc.
Series A Convertible Preferred Stock 		A - Award 24,785 24,785 403.47 9,999,999 9,999,999
2023-06-30 2023-06-28 4 MORF Morphic Holding, Inc.
Common Stock 		J - Other 429 2,768,893 0.02
2023-06-30 2023-06-28 4 MORF Morphic Holding, Inc.
Common Stock 		J - Other 429 2,768,893 0.02
2023-05-04 2023-05-03 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 1,050,000 2,768,464 61.10 45.00 47,250,000 124,580,880
2023-02-13 2023-02-13 4 MORF Morphic Holding, Inc.
Common Stock 		A - Award 806,223 1,718,464 88.38 35.35 28,499,983 60,747,702
2023-02-13 2023-02-13 4 MORF Morphic Holding, Inc.
Common Stock 		A - Award 42,432 4,607,623 0.93 35.35 1,499,971 162,879,473
2022-04-29 2021-06-16 4/A MORF Morphic Holding, Inc.
Director Stock Option (right to buy) 		A - Award 9,996 9,996
2022-04-13 2022-04-11 4 SELB SELECTA BIOSCIENCES INC
Warrant (right to buy) 		A - Award 5,011,200 5,011,200
2022-04-13 2022-04-11 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 6,681,600 29,868,490 28.82
2022-01-05 2022-01-03 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) 		A - Award 40,000 40,000
2021-12-17 2021-12-15 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 211,190 23,186,890 0.92 2.99 631,099 69,289,383
2021-12-13 2021-12-13 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 14,592 22,975,700 0.06 2.98 43,491 68,479,074
2021-12-13 2021-12-10 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 58,681 22,961,108 0.26 2.99 175,439 68,646,825
2021-12-13 2021-12-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 3,748,000 22,902,427 19.57 3.06 11,468,880 70,081,427
2021-08-20 2021-08-20 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 11,511 912,241 1.28 56.80 653,839 51,816,383
2021-08-20 2021-08-20 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 109 900,730 0.01 56.01 6,105 50,448,896
2021-08-20 2021-08-19 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 13,874 900,621 1.56 56.82 788,339 51,174,456
2021-08-20 2021-08-19 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 18,916 886,747 2.18 56.31 1,065,183 49,933,788
2021-08-20 2021-08-19 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 210 867,831 0.02 54.71 11,488 47,475,302
2021-08-20 2021-08-18 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 9,208 867,621 1.07 56.35 518,845 48,888,014
2021-08-20 2021-08-18 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 21,099 858,413 2.52 55.42 1,169,357 47,575,309
2021-06-17 2021-06-16 4 MORF Morphic Holding, Inc.
Director Stock Option (right to buy) 		A - Award 12,000 12,000
2021-05-26 2021-05-26 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 926,170 19,154,427 5.08 4.00 3,705,699 76,638,778
2021-05-26 2021-05-25 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 383,830 18,228,257 2.15 3.55 1,362,098 64,686,616
2021-05-26 2021-05-24 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 590,000 17,844,427 3.42 3.38 1,992,076 60,249,923
2021-05-26 2021-05-26 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 2,413 837,314 0.29 47.36 114,285 39,657,117
2021-05-26 2021-05-26 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 22,587 834,901 2.78 46.93 1,060,015 39,182,154
2021-05-26 2021-05-25 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 8,441 812,314 1.05 46.11 389,225 37,456,855
2021-05-26 2021-05-25 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 56,559 803,873 7.57 45.83 2,592,156 36,842,303
2021-05-26 2021-05-24 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 7,550 747,314 1.02 47.10 355,586 35,196,621
2021-05-26 2021-05-24 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 27,426 739,764 3.85 46.54 1,276,491 34,430,910
2021-05-26 2021-05-24 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 5,024 712,338 0.71 45.43 228,234 32,360,661
2021-05-25 2021-05-21 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 2,773,479 17,254,427 19.15 3.19 8,847,398 55,041,622
2021-05-25 2021-05-21 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 232,295 707,314 48.90 45.50 10,569,422 32,182,787
2021-04-01 2021-03-30 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) 		A - Award 40,000 40,000
2021-03-08 2021-03-05 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 100,000 475,019 26.67 70.00 7,000,000 33,251,330
2020-10-23 2020-10-23 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 994,488 14,480,948 7.37 2.71 2,699,737 39,311,430
2020-10-23 2020-10-22 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 1,770,204 13,486,460 15.11 2.63 4,656,699 35,477,482
2020-10-23 2020-10-21 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 880,000 11,716,256 8.12 2.50 2,199,472 29,283,610
2020-10-20 2020-10-20 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 910,000 10,836,256 9.17 2.21 2,013,193 23,973,049
2020-10-20 2020-10-19 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 759,500 9,926,256 8.29 2.36 1,795,002 23,459,713
2020-10-20 2020-10-16 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 218,196 9,166,756 2.44 2.42 528,034 22,183,550
2020-10-14 2020-10-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 276,703 8,948,560 3.19 2.00 552,465 17,866,695
2020-10-08 2020-10-08 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 530,441 8,671,857 6.52 1.89 1,000,836 16,362,060
2020-10-08 2020-10-07 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 654,953 8,141,416 8.75 1.65 1,078,577 13,407,284
2020-10-08 2020-10-06 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 2,000,000 7,486,463 36.45 1.68 3,365,800 12,598,969
2020-06-23 2020-06-19 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) 		A - Award 20,000 20,000
2020-06-19 2020-06-18 4 MORF Morphic Holding, Inc.
Director Stock Option (right to buy) 		A - Award 12,000 12,000
2019-12-26 2019-12-23 4 SELB SELECTA BIOSCIENCES INC
Warrants 		A - Award 1,970,443 1,970,443 0.12 246,305 246,305
2019-12-26 2019-12-23 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		A - Award 3,940,887 5,486,463 254.98 1.46 5,753,695 8,010,236
2019-12-16 2019-12-12 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		J - Other 1,237,028 7,293,625 20.42
2019-12-12 2019-12-10 4 SRRK Scholar Rock Holding Corp
Common Stock 		G - Gift -296,000 2,376,567 -11.08
2019-12-09 2019-12-05 4 MORF Morphic Holding, Inc.
Stock Option (right to buy Common Stock) 		A - Award 90,000 90,000
2019-09-05 2019-09-03 4 SELB Scholar Rock Holding Corp
Common Stock 		J - Other -1,237,028 0 -100.00
2019-09-05 2019-09-03 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		J - Other -1,237,028 0 -100.00
2019-08-21 2019-08-19 4 SRRK Scholar Rock Holding Corp
Common Stock 		G - Gift -296,000 2,672,567 -9.97
2019-08-20 2019-08-20 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		A - Award 1,100,000 1,545,576 246.87 1.81 1,991,000 2,797,493
2019-08-20 2019-08-20 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		A - Award 1,600,000 6,056,597 35.90 1.81 2,896,000 10,962,441
2019-08-16 2019-08-14 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 10,000 86,418 13.09 1.74 17,415 150,497
2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Series Seed Preferred Stock 		C - Conversion -341,686 0 -100.00
2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Series B Preferred Stock 		C - Conversion -1,345,569 0 -100.00
2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Series A Preferred Stock 		C - Conversion -2,286,588 0 -100.00
2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Series Seed Preferred Stock 		C - Conversion -332,805 0 -100.00
2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock 		P - Purchase 33,333 375,019 9.76 15.00 499,995 5,625,285
2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock 		C - Conversion 341,686 341,686
2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock 		C - Conversion 1,345,569 4,565,191 41.79
2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock 		C - Conversion 2,286,588 3,219,622 245.07
2019-07-01 2019-07-01 4 MORF Morphic Holding, Inc.
Common Stock 		C - Conversion 332,805 933,034 55.45
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 		1,457,698
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 		900,342
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 		1,071,836
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 		1,457,698
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 		900,342
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 		1,071,836
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 		1,457,698
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 		900,342
2019-06-26 3 MORF Morphic Holding, Inc.
Common Stock 		1,071,836
2019-06-18 2019-06-14 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) 		A - Award 10,000 10,000
2019-03-29 2019-01-25 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 66,666 76,418 683.61 1.50 99,999 114,627
2019-03-29 2019-01-25 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 4,000,000 4,456,597 876.05 1.50 6,000,000 6,684,896
2019-03-29 2017-11-10 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 4,752 9,752 95.04 9.03 42,906 88,051
2018-06-26 2018-06-22 4 SRRK Scholar Rock Holding Corp
Stock Option (right to buy) 		A - Award 20,316 20,316
2018-06-19 2018-06-15 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) 		A - Award 10,000 10,000
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series A-4 Preferred 		C - Conversion -787,649 0 -100.00
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series C Preferred 		C - Conversion -855,391 0 -100.00
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series B Preferred 		C - Conversion -2,094,875 0 -100.00
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series A-3 Preferred 		C - Conversion -1,449,275 0 -100.00
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series A-2 Preferred 		C - Conversion -1,491,792 0 -100.00
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Series A-1 Preferred 		C - Conversion -1,000,000 0 -100.00
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock 		C - Conversion 275,903 275,903
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock 		P - Purchase 71,428 3,273,519 2.23 14.00 999,992 45,829,266
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock 		C - Conversion 299,632 3,202,091 10.32
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock 		C - Conversion 733,808 2,902,459 33.84
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock 		C - Conversion 507,662 2,168,651 30.56
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock 		C - Conversion 522,556 1,660,989 45.90
2018-05-31 2018-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock 		C - Conversion 350,287 1,138,433 44.44
2018-05-23 3 SRRK Scholar Rock Holding Corp
Common Stock 		1,576,292
2018-05-23 3 SRRK Scholar Rock Holding Corp
Common Stock 		1,576,292
2017-11-16 2017-11-14 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 57,598 461,349 14.27 9.27 534,095 4,277,997
2017-11-13 2017-11-10 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 4,752 403,751 1.19 9.03 42,906 3,645,468
2017-11-13 2017-11-10 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 21,586 398,999 5.72 9.04 195,191 3,607,948
2017-11-13 2017-11-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 100 5,000 2.04 9.78 978 48,900
2017-11-13 2017-11-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 4,900 4,900 9.33 45,703 45,703
2017-11-13 2017-11-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 900 377,413 0.24 9.74 8,767 3,676,267
2017-11-13 2017-11-09 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 21,100 376,513 5.94 9.33 196,893 3,513,393
2017-06-28 2017-06-27 4 SELB SELECTA BIOSCIENCES INC
Warrant (right to buy) 		P - Purchase 79,130 79,130 0.12 9,891 9,891
2017-06-28 2017-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 338,791 355,413 2,038.21 17.71 5,999,989 6,294,364
2017-06-20 2017-06-16 4 SELB SELECTA BIOSCIENCES INC
Stock Option (Right to Buy) 		A - Award 6,410 6,410
2017-06-02 2017-06-01 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 518 16,622 3.22 13.75 7,122 228,552
2017-05-19 2017-05-18 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 4,860 16,104 43.22 14.00 68,040 225,456
2017-05-19 2017-05-17 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 11,244 11,244 14.01 157,483 157,483
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series E Convertible Preferred Stock 		C - Conversion -79,156 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series E Convertible Preferred Stock 		C - Conversion -84,421 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series D Convertible Preferred Stock 		C - Conversion -51,355 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series D Convertible Preferred Stock 		C - Conversion -63,547 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series C Convertible Preferred Stock 		C - Conversion -93,954 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series C Convertible Preferred Stock 		C - Conversion -153,742 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series B Convertible Preferred Stock 		C - Conversion -157,864 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series B Convertible Preferred Stock 		C - Conversion -157,864 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 710,000 1,237,028 134.72 14.00 9,940,000 17,318,392
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		C - Conversion 425,874 445,576 2,161.58
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		C - Conversion 506,015 527,028 2,408.10
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		61,728
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		60,417
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		61,728
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		60,417
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		61,728
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		60,417
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		61,728
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		60,417
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）